Cargando…
Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial)
INTRODUCTION: Retinitis pigmentosa (RP) is a severe neurodegenerative disease of the retina that can lead to blindness. Even without treatment, a clinical study with the use of stem cells is currently underway and the results are being evaluated. In the present report we assess the vision-related qu...
Autores principales: | Siqueira, Rubens C, Messias, Andre, Messias, Katharina, Arcieri, Rafael S, Ruiz, Milton A, Souza, Neiglene F, Martins, Lia C, Jorge, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393588/ https://www.ncbi.nlm.nih.gov/pubmed/25890251 http://dx.doi.org/10.1186/s13287-015-0020-6 |
Ejemplares similares
-
Intravitreal use of bone marrow mononuclear fraction containing CD34(+) stem cells in patients with atrophic age-related macular degeneration
por: Cotrim, Carina Costa, et al.
Publicado: (2017) -
Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy
por: Cotrim, Carina Costa, et al.
Publicado: (2020) -
Intravitreal Injection of Bone Marrow Mesenchymal Stem Cells in Patients with Advanced Retinitis Pigmentosa; a Safety Study
por: Satarian, Leila, et al.
Publicado: (2017) -
Long-Term Effects of Adjuvant Intravitreal Treatment with Autologous Bone Marrow-Derived Lineage-Negative Cells in Retinitis Pigmentosa
por: Wiącek, Marta P., et al.
Publicado: (2021) -
Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
por: Saatci, Ali Osman, et al.
Publicado: (2013)